PwC Tax and Advisory (Vietnam) Company Limited (“PwC Vietnam”) Successfully Advised Gene Solutions on Strategic Fundraising with August Global Partners Pte. Ltd. ("AGP")

Established in 2017, Gene Solutions has emerged as a pioneering biotech company in Asia, recognized for its innovative genetics, non-invasive prenatal and cancer screening testing solutions along with extensive clinical validation published in globally-recognized scientific journals. Gene Solutions has demonstrated commercial success in cell-free DNA testing across South East Asia and is expanding its product pipeline in cancer screening and personalized cancer care. This includes early cancer detection and monitoring tests, as well as collaborations with biopharma leaders to co-develop novel cancer therapeutics.

AGP is an independent fund management company focused on healthcare investments, ranging from venture to growth-stage. Spun out from EDBI – the Singapore state-owned strategic fund, AGP manages significant assets in the healthcare sector. AGP's investment will not only provide financial resources but also leverage its substantial expertise in biotechnology and healthcare investments, along with a robust network in the Asia-Pacific region, to support Gene Solutions in pioneering healthcare advancements.

The Corporate Finance team from PwC Vietnam served as the exclusive financial advisors to Gene Solutions in connection with the transaction.